Mike Hollan

The results say that the industry still lacks talent and skills in this area.

The campaign also includes partnerships with other celebrities, including Lance Bass and Retta.

Dorman previously served as head of Gilead Sciences’ U.S. Oncology Unit.

The drug, developed by UCB, is approved to treat adults with the inflammatory skin disease.

Syndax describes the drug as the first of its kind.

The news is part of the organization’s goal of demonstrating a commitment to women’s health.

The contest focused on telling the stories of how migraines impacted patients’ careers.

Etira’s CEO discusses recent developments in R&D and with the company’s leadership.

A look at one biotech’s mission to map the immune system using artificial intelligence—and how its growth as a Big Pharma partner could help unlock the potential of next-generation cancer treatments.

Ann Beliën, PhD, founder and CEO of Rejuvenate Biomed, discusses how AI is being used to find new ways to treat age-related conditions.

The Jazz Pharmaceutical president and COO discusses her approach to the role and how it plays into the company’s overall goals.

The survey is part of an initiative from GSK to improve these gaps.

The company will also change its NASDAQ ticker to ONC.

Pleio’s chief experience officer discusses why these platforms are being embraced by the industry.

Decisions and strategies related to remote work, AI, and DE&I are especially evolving.

EVERSANA's Ryan discusses the company’s recent expansion into new markets in Europe.

Phesi’s founder and president discusses methods of improving the site selection process.

Familial Chylomicronemia Syndrome is a rare condition that can have deadly symptoms.

The campaign is focused on providing guidance for newly diagnosed patients.

Agents were informed that they would no longer receive commissions for select signs up as of November 1.

How will President Trump’s return to office impact the pharma industry?

Padraic Ward discusses the innovation-environment in Europe.

David Reddy discusses negotiations on the global pandemic accord.

Amgen CEO Robert A. Bradway discusses the potential impact of the election, and politics in general, will have on the industry.

Abi Carter is timing the partnership with the release of her upcoming album.

The healthcare company signed a deal with Infirmary Health, who services customers in Georgia and parts of Florida and Mississippi.

The executive director of patient strategies & solutions discusses J&J’s new Guide to Expanded Access.

The alliance’s president discusses the current state of data sharing, security concerns, and the adoption AI.

The president of compliance services discusses the company’s recent expansion into new markets.

The CEO discusses the current state of compounding pharmacies and how it built to this point.